Skip to content

Clinical trials

Melanoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Country / region: United States Clear all

1,971 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200034
200133
200232
200338
200459
200559
200673
200763
200862
200966
201070
201179
201274
201393
201475
2015104
201687
201779
201893
201985
202080
2021101
202281
202373
202461
202559
202642

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,037
Terminated400
Recruiting199
Active, not recruiting174
Unknown status65
Withdrawn52
Not yet recruiting19
Suspended15
Enrolling by invitation5
No longer available3
Available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)198
M.D. Anderson Cancer Center96
Bristol-Myers Squibb64
Memorial Sloan Kettering Cancer Center63
Mayo Clinic40
H. Lee Moffitt Cancer Center and Research Institute36
Novartis Pharmaceuticals35
Pfizer34
Hoffmann-La Roche22
Dana-Farber Cancer Institute20

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma1,971
Carcinoma, Non-Small-Cell Lung303
Carcinoma, Renal Cell227
Neoplasms224
Neoplasm Metastasis205
Breast Neoplasms203
Colorectal Neoplasms171
Skin Neoplasms146
Lung Neoplasms144
Ovarian Neoplasms141

Trials

Showing 1 to 25 of 1,971. Each trial links to its page on Pharma Observatory.

1,871 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.